Jonas Leubner

731 total citations
9 papers, 111 citations indexed

About

Jonas Leubner is a scholar working on Neurology, Molecular Biology and Cell Biology. According to data from OpenAlex, Jonas Leubner has authored 9 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 3 papers in Molecular Biology and 2 papers in Cell Biology. Recurrent topics in Jonas Leubner's work include Autoimmune Neurological Disorders and Treatments (4 papers), Glycogen Storage Diseases and Myoclonus (1 paper) and Genomics and Rare Diseases (1 paper). Jonas Leubner is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (4 papers), Glycogen Storage Diseases and Myoclonus (1 paper) and Genomics and Rare Diseases (1 paper). Jonas Leubner collaborates with scholars based in Germany, United Kingdom and Netherlands. Jonas Leubner's co-authors include Harald Prüß, Nina K. Wenke, Claudia A. Szentiks, Alex D. Greenwood, Jakob Kreye, Gábor Á. Czirják, S. Momsen Reincke, Johannes Lemcke, Marcus Quinkler and M Ventz and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Neurology and Scientific Reports.

In The Last Decade

Jonas Leubner

7 papers receiving 110 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonas Leubner Germany 5 79 29 28 23 13 9 111
Marie Bénaiteau France 6 86 1.1× 17 0.6× 18 0.6× 26 1.1× 15 1.2× 24 140
Aurélien Maureille France 5 79 1.0× 17 0.6× 15 0.5× 14 0.6× 17 1.3× 9 128
Rongjuan Zhao China 6 31 0.4× 8 0.3× 33 1.2× 14 0.6× 9 0.7× 24 106
Sofia Bergström Sweden 8 30 0.4× 7 0.2× 41 1.5× 11 0.5× 8 0.6× 15 133
Martin Elišák Czechia 4 122 1.5× 25 0.9× 25 0.9× 21 0.9× 24 1.8× 15 142
Amber Stocco United States 3 196 2.5× 58 2.0× 15 0.5× 34 1.5× 33 2.5× 5 209
Hanène Benrhouma Tunisia 8 57 0.7× 21 0.7× 62 2.2× 25 1.1× 7 0.5× 37 150
Jessica M. Phan United States 4 79 1.0× 15 0.5× 109 3.9× 10 0.4× 7 0.5× 5 186
Deepti Pilli Australia 4 52 0.7× 8 0.3× 23 0.8× 9 0.4× 10 0.8× 5 95
Christopher A. Naranjo United States 4 21 0.3× 12 0.4× 48 1.7× 49 2.1× 6 0.5× 8 114

Countries citing papers authored by Jonas Leubner

Since Specialization
Citations

This map shows the geographic impact of Jonas Leubner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Leubner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Leubner more than expected).

Fields of papers citing papers by Jonas Leubner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Leubner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Leubner. The network helps show where Jonas Leubner may publish in the future.

Co-authorship network of co-authors of Jonas Leubner

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Leubner. A scholar is included among the top collaborators of Jonas Leubner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Leubner. Jonas Leubner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Leubner, Jonas, Felix Boschann, Nadja Ehmke, et al.. (2025). Novel Biallelic SQSTM1 Mutation Causing a Subacute‐Onset Complex Movement Disorder with Oculomotor Abnormalities. Movement Disorders Clinical Practice. 12(11). 1995–2000.
2.
Neuhann, Teresa, Eva‐Christina Prott, Jonas Leubner, et al.. (2024). LZTR1 loss-of-function variants associated with café au lait macules with or without freckling. Frontiers in Neurology. 15. 1391425–1391425. 1 indexed citations
3.
Batchelor, Hannah, Pamela Dicks, Ségolène Gaillard, et al.. (2023). Optimizing expert and patient input in pediatric trial design: Lessons learned and recommendations from a collaboration between conect4children and European Patient‐CEntric ClinicAl TRial PLatforms. Clinical and Translational Science. 16(8). 1458–1468. 2 indexed citations
4.
Bakker, Annette, Rosalie E. Ferner, D. Gareth Evans, et al.. (2023). A basket-platform trial for neurofibromatosis type 1: A potential model for rare cancer predisposition syndromes.. Journal of Clinical Oncology. 41(16_suppl). e22550–e22550.
5.
Wenke, Nina K., Jakob Kreye, Jonas Leubner, et al.. (2019). N‐methyl‐D‐aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit. Annals of Neurology. 85(5). 771–776. 32 indexed citations
6.
Kreye, Jakob, Betty Jurek, Jonas Leubner, et al.. (2018). Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics. Journal of Neurology. 265(11). 2625–2632. 28 indexed citations
7.
Berger, Benjamin, Tilman Hottenrott, Jonas Leubner, et al.. (2015). Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis. BMC Neurology. 15(1). 255–255. 5 indexed citations
8.
Prüß, Harald, Jonas Leubner, Nina K. Wenke, et al.. (2015). Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus) Knut. Scientific Reports. 5(1). 12805–12805. 32 indexed citations
9.
Leubner, Jonas, et al.. (2014). Sexual Well-Being in Adult Male Patients with Congenital Adrenal Hyperplasia. International Journal of Endocrinology. 2014. 1–9. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026